Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Pharmacology
  4. Neuroprotection and immunomodulation by dimethyl fumarate and a heterologous fibrin biopolymer after ventral root avulsion and reimplantation

Neuroprotection and immunomodulation by dimethyl fumarate and a heterologous fibrin biopolymer after ventral root avulsion and reimplantation

J Venom Anim Toxins incl Trop Dis, 2020 · DOI: 10.1590/1678-9199-JVATITD-2019-0093 · Published: May 20, 2020

PharmacologyRegenerative MedicineNeurology

Simple Explanation

Ventral root avulsion (VRA) is an experimental model where motor roots are abruptly separated from the spinal cord, leading to motoneuron degeneration and inflammation. Treatment with dimethyl fumarate (DMF), known for its neuroprotective and immunomodulatory effects, combined with a fibrin sealant (FS), a biological glue, can potentially improve the regenerative response after VRA. The study hypothesizes that this combined approach of DMF and FS may promote neuroprotection, preservation, and recovery of motor function after spinal cord injuries.

Study Duration
12 weeks
Participants
Seventy-nine adult female Lewis rats
Evidence Level
Not specified

Key Findings

  • 1
    DMF treatment at 15 mg/kg preserved motoneurons and synapses and decreased astrogliosis and microglial reactions, downregulating pro-inflammatory gene transcripts.
  • 2
    The combination of DMF and fibrin sealant (FS) further enhanced the pharmacological benefit, allowing animals to recover at least 50% of motor function.
  • 3
    This combined approach promotes a balance between anti- and pro-inflammatory cytokines, favoring an anti-inflammatory state, and influences macrophage polarization.

Research Summary

The study investigates the neuroprotective and immunomodulatory effects of dimethyl fumarate (DMF) combined with a heterologous fibrin sealant (FS) following ventral root avulsion (VRA) and reimplantation in rats. Results showed that DMF treatment, particularly at 15 mg/kg, preserved motoneurons and synapses, reduced glial reactivity, and downregulated pro-inflammatory gene expression. The combination of DMF and FS further enhanced neuronal survival, synaptic preservation, and motor function recovery, suggesting a promising therapeutic approach for spinal cord injuries.

Practical Implications

Therapeutic Potential

The combined approach of DMF and FS shows promise as a therapeutic strategy for spinal cord injuries, potentially improving neuronal survival and motor function recovery.

Clinical Translation

The findings support the translation of this combined pharmacological and surgical approach to clinical settings for patients with spinal cord injuries.

Optimized Dosage

The study identifies an optimal dosage of DMF (15 mg/kg) for achieving neuroprotective and immunomodulatory effects in VRA, which is crucial for clinical application.

Study Limitations

  • 1
    The study was conducted on rats, and results may not directly translate to humans.
  • 2
    The specific mechanisms underlying the neuroprotective and immunomodulatory effects of DMF and FS require further investigation.
  • 3
    The long-term effects of the combined treatment approach need to be evaluated in future studies.

Your Feedback

Was this summary helpful?

Back to Pharmacology